UNVERIFIEDSingle SourceLG Chem targets ‘undruggable’ p53 with new cancer drug dealThe Korea Herald|4/2/2026
UNVERIFIEDSingle SourcePhase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated TumorsNEJM|2/25/2026
UNVERIFIEDSingle SourceEditorial Expression of Concern: Transcription-independent ARF regulation in oncogenic stress-mediated p53 responsesNature|2/16/2026
UNVERIFIEDSingle SourceEditorial Expression of Concern: Deacetylation of p53 modulates its effect on cell growth and apoptosisNature|2/16/2026